LEADER 01629nas  2200493-a 450 
001 996198097903316
005 20240413024428.0
011   $a2230-6064
035   $a(CKB)111022269525008
035   $a(CONSER)--2002243337
035   $a(EXLCZ)99111022269525008
100   $a20011127b20022006  ---         a
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAmerican journal of cancer $edrugs, diagnostics, and other interventions
210   $aAuckland, N.Z. $cAdis International$dİ2002-
215   $a1 online resource
300   $aRefereed/Peer-reviewed
300   $aTitle from cover.
311 08$aPrint version: American journal of cancer (Auckland, N.Z.) 1175-6357 (DLC)  2002243337 (OCoLC)50198210 
531   $aAM J CANCER
531 1 $aAm. j. cancer
606   $aCancer$xTreatment$vPeriodicals
606   $aAntineoplastic agents$vPeriodicals
606   $aNeoplasms$xtherapy
606   $aAntineoplastic Agents$xtherapeutic use
606   $aAntineoplastic agents$2fast$3(OCoLC)fst00810595
606   $aCancer$xTreatment$2fast$3(OCoLC)fst00845538
608   $aPeriodicals.
608   $aPeriodicals.$2fast
615  0$aCancer$xTreatment
615  0$aAntineoplastic agents
615 12$aNeoplasms$xtherapy.
615 22$aAntineoplastic Agents$xtherapeutic use.
615  7$aAntineoplastic agents.
615  7$aCancer$xTreatment.
906   $aJOURNAL
912   $a996198097903316
920   $aexl_impl conversion
996   $aAmerican journal of cancer$92493374
997   $aUNISA